Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    October 2022
  1. BOSSE Y, Gagne A, Althakfi W, Orain M, et al
    Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
    Hum Pathol. 2022;128:56-68.
    PubMed     Abstract available

  2. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
    A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Hum Pathol. 2022;128:31-47.
    PubMed     Abstract available

    August 2022
  3. CHANG WC, Yeh YC, Ho HL, Chou TY, et al
    Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
    Hum Pathol. 2022;126:9-18.
    PubMed     Abstract available

    May 2022
  4. AMBROSINI-SPALTRO A, Farnedi A, Calistri D, Rengucci C, et al
    The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies' integration.
    Hum Pathol. 2022;123:20-30.
    PubMed     Abstract available

    April 2022
  5. LIU L, Wei J, Teng F, Zhu Y, et al
    Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84-92].
    Hum Pathol. 2022;125:1.

  6. ISHIKAWA R, Kadota K, Ikeda T, Yoshida C, et al
    Prognostic Impact of Tumor-infiltrating Lymphocytes and Neutrophils in Resected Non-small Cell Lung Carcinoma.
    Hum Pathol. 2022 Apr 25. pii: S0046-8177(22)00102.
    PubMed     Abstract available

    March 2022
  7. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    PubMed     Abstract available

    February 2022
  8. MOAYED-ALAEI L, Vargas AC, Adybeik D, Maclean F, et al
    Analyzing the morphological spectrum of epithelioid fibrous histiocytoma and the immunohistochemical performance of the ALK D5F3 and ALK1 clones.
    Hum Pathol. 2022;120:46-56.
    PubMed     Abstract available

    December 2021
  9. LAWLOR RT, Mafficini A, Sciammarella C, Cantu C, et al
    Genomic characterization of hepatoid tumors: context matters.
    Hum Pathol. 2021;118:30-41.
    PubMed     Abstract available

    September 2021
  10. WANG M, Abi-Raad R, Baldassarri R, Adeniran AJ, et al
    Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Hum Pathol. 2021;115:104-111.
    PubMed     Abstract available

  11. TONNESEN E, Lade-Keller J, Stougaard M
    Frequently used quantitative polymerase chain reaction-based methods overlook potential clinically relevant genetic alterations in epidermal growth factor receptor compared with next-generation sequencing: a retrospective clinical comparison of 1839 l
    Hum Pathol. 2021;115:67-75.
    PubMed     Abstract available

  12. CHEN M, Yang J, Lv L, Li Y, et al
    Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.
    Hum Pathol. 2021;115:56-66.
    PubMed     Abstract available

    August 2021
  13. WANG B, Chen R, Wang C, Guo J, et al
    Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
    Hum Pathol. 2021;114:90-98.
    PubMed     Abstract available

    March 2021
  14. ITAMI H, Fujii T, Nakai T, Takeda M, et al
    TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared to malignant mesothelioma.
    Hum Pathol. 2021 Mar 2. pii: S0046-8177(21)00032.
    PubMed     Abstract available

    February 2021
  15. YANAGAWA N, Shiono S, Endo M, Ogata SY, et al
    Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Hum Pathol. 2021;108:12-21.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.